Chapman Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Sell
6,705
-13
-0.2% -$3.03K 1.13% 20
2026
Q1
$1.64M Buy
6,718
+42
+0.6% +$9.78K 1.18% 18
2025
Q4
$1.38M Sell
6,676
-315
-5% -$62.3K 0.94% 25
2025
Q3
$1.3M Sell
6,991
-1,128
-14% -$193K 0.9% 27
2025
Q2
$1.24M Buy
+8,119
New +$1.25M 1.05% 31
2024
Q4
$1.23M Buy
+8,480
New +$1.31M 0.98% 32

Other funds holding JNJ

Chapman Financial Group's JNJ Position: Q2 2026 in Review

Chapman Financial Group reduced its Johnson & Johnson (JNJ) stake by 0.19% in Q2 2026, selling an estimated $3.03K and leaving 6,705 shares worth $1.7M. The position accounts for 1.13% of the portfolio, ranked #20.

Chapman Financial Group first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Chapman Financial Group held 6,705 shares of Johnson & Johnson worth $1.7M as of Q2 2026.
  • Chapman Financial Group sold 13 Johnson & Johnson shares in Q2 2026, an estimated $3.03K.
  • Johnson & Johnson made up 1.13% of Chapman Financial Group's portfolio in Q2 2026, its #20 holding.
  • Chapman Financial Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Chapman Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.